Dermira – $194 Million Shelf-Takedown

San Diego – March 10, 2017 – Cooley advised the underwriters on Dermira’s $193.8 million shelf-takedown offering of 5,750,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares.

Leerink Partners, Evercore ISI and Guggenheim Securities acted as joint book-running managers for the offering. Needham & Company acted as co-manager.

Dermira, which trades on The NASDAQ Global Select Market as “DERM,” is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Charlie Kim  Partner San Diego, Los Angeles – Santa Monica
Drew Williamson  Partner San Francisco
David Peinsipp  Partner San Francisco, Palo Alto
Kristin VanderPas  Partner San Francisco
Denny Won  Partner San Francisco
Phillip McGill  Associate San Diego
Stephanie Leigh  Paralegal Specialist San Diego
Natasha Leskovsek  Of Counsel Washington, DC
Phil Mitchell  Partner New York
Bill Christiansen  Partner Seattle
Kevin King  Partner Washington, DC
Rebecca Ross  Special Counsel Washington, DC
Darren DeStefano  Partner Reston